Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B R Binder

Showing results (71-80 of 219) with videos related to

Pageof 22
Sort By:
Thrombosis and Haemostasis|October 30, 1985
Does plasma urokinase antigen reflect tumor urokinase in prostatic carcinoma?J C Kirchheimer, B R Binder, H Pflueger, et al.
Thrombosis Research|June 1, 1991
Hepatic synthesis and clearance of components of the fibrinolytic system in healthy volunteers and in patients with different stages of liver cirrhosisK Huber, J C Kirchheimer, C Korninger, et al.
The Journal of Urology|December 1, 1988
Urokinase-type plasminogen activator as a marker for the formation of distant metastases in prostatic carcinomasG Hienert, J C Kirchheimer, H Pflüger, et al.
European Journal of Clinical Investigation|February 1, 1990
Relationship between plasma levels of components of the fibrinolytic system and acute-phase reactants in patients with uterine malignanciesJ C Kirchheimer, H Kölbl, G Tatra, et al.
Gene Therapy|May 1, 1997
Adenovirus-mediated expression of green fluorescent proteinR de Martin, M Raidl, E Hofer, et al.
Thrombosis and Haemostasis|October 30, 1985
Urokinase antigen in plasma of patients with liver cirrhosis and hepatomaJ C Kirchheimer, K Huber, P Polterauer, et al.
British Journal of Haematology|May 1, 1987
Pattern of fibrinolytic parameters in patients with gastrointestinal carcinomasJ C Kirchheimer, K Huber, O Wagner, et al.
The Journal of Biological Chemistry|June 25, 1991
Urinary protein C inhibitor. Glycosaminoclycans synthesized by the epithelial kidney cell line TCL-598 enhance its interaction with urokinaseM Geiger, U Priglinger, J H Griffin, et al.
Thrombosis and Haemostasis|April 25, 1989
Evaluation of fibrinolytic capacity in plasma during thrombolytic therapy with single (scu-PA) or two-chain urokinase type plasminogen activator (tcu-PA) by a combined assay system for urokinase type plasminogen activator antigen and functionJ Wojta, B R Binder, K Huber, et al.
The American Journal of Physiology|June 1, 1988
Comparison of fibrinolytic activities of human and bovine endothelial cellsK Bartha, J Wojta, O F Wagner, et al.
Pageof 22

Showing results (71-80 of 219) with videos related to

Sort By:
Pageof 22
Thrombosis and Haemostasis|October 30, 1985
Does plasma urokinase antigen reflect tumor urokinase in prostatic carcinoma?J C Kirchheimer, B R Binder, H Pflueger, et al.
Thrombosis Research|June 1, 1991
Hepatic synthesis and clearance of components of the fibrinolytic system in healthy volunteers and in patients with different stages of liver cirrhosisK Huber, J C Kirchheimer, C Korninger, et al.
The Journal of Urology|December 1, 1988
Urokinase-type plasminogen activator as a marker for the formation of distant metastases in prostatic carcinomasG Hienert, J C Kirchheimer, H Pflüger, et al.
European Journal of Clinical Investigation|February 1, 1990
Relationship between plasma levels of components of the fibrinolytic system and acute-phase reactants in patients with uterine malignanciesJ C Kirchheimer, H Kölbl, G Tatra, et al.
Gene Therapy|May 1, 1997
Adenovirus-mediated expression of green fluorescent proteinR de Martin, M Raidl, E Hofer, et al.
Thrombosis and Haemostasis|October 30, 1985
Urokinase antigen in plasma of patients with liver cirrhosis and hepatomaJ C Kirchheimer, K Huber, P Polterauer, et al.
British Journal of Haematology|May 1, 1987
Pattern of fibrinolytic parameters in patients with gastrointestinal carcinomasJ C Kirchheimer, K Huber, O Wagner, et al.
The Journal of Biological Chemistry|June 25, 1991
Urinary protein C inhibitor. Glycosaminoclycans synthesized by the epithelial kidney cell line TCL-598 enhance its interaction with urokinaseM Geiger, U Priglinger, J H Griffin, et al.
Thrombosis and Haemostasis|April 25, 1989
Evaluation of fibrinolytic capacity in plasma during thrombolytic therapy with single (scu-PA) or two-chain urokinase type plasminogen activator (tcu-PA) by a combined assay system for urokinase type plasminogen activator antigen and functionJ Wojta, B R Binder, K Huber, et al.
The American Journal of Physiology|June 1, 1988
Comparison of fibrinolytic activities of human and bovine endothelial cellsK Bartha, J Wojta, O F Wagner, et al.
Pageof 22